Brief: InMed Pharmaceuticals Reports Q3 Net Loss Per Share Of $0.25

InMed Pharmaceuticals

13/05/2022 12:40

May 13 (Reuters) - InMed Pharmaceuticals Inc  INM.O :
    * INMED PHARMACEUTICALS REPORTS THIRD QUARTER FISCAL 2022
FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
    * INMED PHARMACEUTICALS INC - QTRLY NET LOSS PER SHARE $0.25

Source text for Eikon:  ID:nGNX38W5pH 
Further company coverage:  INM.O 

 ((Reuters.Briefs@thomsonreuters.com;))